Addressing the Silos to Move Toward an Integrated Approach With Enhanced Trial Design & Execution Across Radiopharmaceutical Research

Time: 8:30 am
day: Workshop D


Radiopharmaceutical development is driven by collaboration between radio pharmacists, nuclear medicine specialists, chemists, bioengineers and more. While the industry is on the brink of expanding their horizons to even more unmet medical needs, there is a clear bottleneck in the blend of expertise required to design and run a radiopharmaceutical trial.

Learn perspectives from key clinicians and industry players to learn exactly how the field can operationalize clinical research:

  • Identify the bottlenecks to uncover areas to be streamlined
  • Explore specialized training solutions
  • Integrating the sponsor and the clinicians toward a unified end goal
  • Maintaining a patient-centric approach in trial design
  • Enhancing integration of nuclear medicine in the clinic
  • Understanding new challenges specific to alpha emitters